Expansion of the fungicide portfolio through the acquisition of the quinoxyfen business and resulting impairment

An individual acquisition in which the quinoxyfen business was acquired from Corteva Agriscience to expand the fungicide portfolio. The earnings outlook deteriorated after the acquisition, resulting in an impairment loss.